ClinicalTrials.gg
Status unknownNCT05397054Updated Jun 8, 2022

Intervention for Monitoring of Salt Intake in Hypertensive Patients

An interventional study of Education and Reformulation in Hypertension and Salt; Excess, sponsored by Mahidol University. Status unknown at 1 site in Thailand. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-06-08.

Sponsored by Mahidol University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jun 2022), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jan 2022, registered May 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Sodium is an essential nutrient for humans, but excessive sodium consumption is causally associated with high blood pressure and increase risk of cardiovascular diseases. Dietary sodium consumption of greater than the recommended daily amount of 5 grams of salt or 2,000 mg of sodium is a major risk factor for CVD-related mortality. From recent national survey, Thai people had consumed more than 9.1 g of salt per day, which was nearly two times above WHO reference level. Dietary salt reduction was unsuccessful because of lacking awareness, and the higher threshold to detect salt taste in chronic high salt ingestion. To create awareness in the community, we should be educated, managed the environmental for salt reduction, and used salt meter to detect sodium content in daily food. This study aimed to compare the efficacy of intervention; education, reformulation, environmental change and used salt meter compared with standard treatment alone in terms of salt intake reduction and blood pressure.

Read the detailed description

A randomized-controlled trial was conducted in adult 18-70 years old with hypertensive patients (SBP>130 mmHg) in Uthaithani. Participants were randomized to intervention groups (education, reformulation, environmental change and used salt meter) and control group (standard education and treatment). Trial was followed up for 12 weeks. The primary objective was change in 24-hour urinary sodium excretion between groups and secondary objectives was change in systolic and diastolic blood pressure.

02

Conditions studied

  • Hypertension
  • Salt; Excess

Browse trials for

Keywords

  • hypertension
  • salt
  • salt reduction
03

In context

Hypertension

6,834 studies on the registry are indexed under Hypertension; 971 are open to participants now.

This study's planned enrollment of 240 is above the median of 90 across 5,095 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Mahidol University is the lead sponsor of 744 studies on the registry; 116 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults 18-70 years of age with hypertension
  • Systolic blood pressure > 130 mmHg
  • Provided informed consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Participants with end stage kidney disease
  • History of adjust antihypertensive agents or diuretic within 2 weeks before enrollment
  • Pregnant or breastfeeding women
  • Adjustment of any antihypertensive agents during study period
  • Participants with salt supplement
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
240 participants (estimated)

Study arms

  • Experimental
    Investigator

    Education, Reformulation, Environmental change, Used salt meter

    Behavioral: Education · Behavioral: Reformulation · Behavioral: Environmental change · Device: Salt meter

  • Active comparator
    Control

    standard treatment with standard education

    Behavioral: standard treatment

Interventions

  • BehavioralEducation

    \- Education: Education about risk of high sodium intake, type of sodium, nutrition ingredients

  • BehavioralReformulation

    \- Reformulation: Dietary recommendation in low sodium intake

  • BehavioralEnvironmental change

    \- Environmental change: Encourage about low sodium intake in community

  • DeviceSalt meter

    \- Used salt meter: at least 3 times/wk

  • Behavioralstandard treatment

    standard treatment

06

What researchers measure

Primary outcomes

  1. 24-hour urine sodium excretion

    Compare the change of 24-hour urine sodium excretion between intervention group, received education, reformulation, environmental change and monitoring of salt intake by salt meter and control group, received standard treatment

    Time frame: 12 weeks

Secondary outcomes

  1. blood pressure

    Compare the change systolic and diastolic blood pressure between intervention group, received education, reformulation, environmental change and monitoring of salt intake by salt meter and control group, received standard treatment

    Time frame: 4, 8 12 weeks

07

Study locations

1 of 1 sites recruiting
  • Faculty of Medicine, Ramathibodi Hospital, Mahidol University
    Bangkok, 10400, Thailand
    • PITCHAPORN SONUCH · Contact
    Recruiting
08

References and documents

Publications

  • Sonuch P, Aekplakorn W, Pomsanthia N, Boonyagarn N, Makkawan S, Thongchai S, Tosamran W, Kunjang A, Kantachuvesiri S. Community-based intervention for monitoring of salt intake in hypertensive patients: A cluster randomized controlled trial. PLoS One. 2024 Nov 22;19(11):e0311908. doi: 10.1371/journal.pone.0311908. eCollection 2024. PubMed 39576798 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05397054
Lead sponsor
Mahidol University
Collaborators
World Health Organization, Thai health promotion foundation.
Responsible party
Sponsor
First posted
May 31, 2022
Start date
Jan 10, 2022
Primary completion
May 30, 2022 (estimated)
Completion
Jun 30, 2022 (estimated)
Last update
Jun 8, 2022

Study contacts

PITCHAPORN SONUCH
Contact
pitch_bell@hotmail.com
022011000

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion